v3.25.4

STOCK-BASED COMPENSATION | 12 Months Ended
--- | ---
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract] |
STOCK-BASED COMPENSATION | STOCK-BASED COMPENSATION Equity Incentive Plan In April 2013, the Board of Directors adopted the EastGroup Properties, Inc. 2013 Equity Incentive Plan (the “2013 Equity Plan”) upon the recommendation of the Compensation Committee of the Company's Board of Directors (the “Committee”); the 2013 Equity Plan was approved by the Company’s stockholders and became effective May 29, 2013. The 2013 Equity Plan was further amended by the Board of Directors in March 2017. The 2013 Equity Plan permitted the grant of awards to employees and directors with respect to 2,000,000 shares of common stock. In April 2023, the Board of Directors adopted the EastGroup Properties, Inc. 2023 Equity Incentive Plan (the “2023 Equity Plan”) upon the recommendation of the Committee; the 2023 Equity Plan was approved by the Company’s stockholders and became effective May 25, 2023. The 2023 Equity Plan permits the grant of awards to employees and directors with respect to 1,500,000 shares of common stock. There were 1,330,959, 1,396,713 and 1,484,116 shares available for grant under the 2023 Equity Plan as of December 31, 2025, 2024 and 2023, respectively. Typically, the Company issues new shares to fulfill stock grants. Employee Equity Awards The Company’s restricted stock program is designed to provide incentives for management to achieve goals established by the Committee. The awards act as a retention device, as they vest over time, allowing participants to benefit from dividends on shares as well as potential stock appreciation. Equity awards align management’s interests with the long-term interests of shareholders. The Committee approves long-term and annual equity compensation awards for the Company’s executive officers. The vesting periods of the Company’s restricted stock plans vary, as determined by the Committee. Restricted stock is granted to executive officers subject to both continued service and the satisfaction of certain annual performance goals and multi-year market conditions as determined by the Committee. Long-term equity compensation awards The long-term compensation awards include components based on the Company’s total shareholder return over the upcoming three-year period and the employee’s continued service as of the vesting dates. The total shareholder return component is subject to bright-line tests that compare the Company’s total shareholder return to the member companies of the Nareit Equity Index and the Nareit industrial index. The following table summarizes the assumptions used in the Monte Carlo simulation pricing model used to determine the grant date fair value of the multi-year market conditions component of the long-term compensation awards for 2025, 2024 and 2023:
| 2025 Award |  | 2024 Award |  | 2023 Award
Valuation date | 2/27/2025 |  | 2/26/2024 |  | 3/2/2023
Risk-free interest rate | 4.21 | % |  | 4.65 | % |  | 4.68 | %
Expected share price volatility for the Company | 22.08 | % |  | 22.85 | % |  | 31.01 | %
Expected share price volatility for peer group companies —Low end of range | 22.74 | % |  | 20.46 | % |  | 27.31 | %
Expected share price volatility for peer group companies —High end of range | 62.28 | % |  | 62.79 | % |  | 51.26 | %
Expected dividend yield | 3.11 | % |  | 2.84 | % |  | 3.02 | %
Number of simulation paths | 1,000,000 |  |  | 1,000,000 |  |  | 1,000,000 |
Grant date fair value (in thousands) | $ | 6,903 |  |  | 4,442 |  |  | 4,885 |
The risk-free interest rate is based on zero coupon risk-free rates matching the three-year time period of the market performance period. The expected share price volatilities are based on a mix of the historical and implied volatilities of the Company and the peer group companies. The expected dividend yield is based on the expected annual cash dividend as of the valuation date divided by the Company’s stock price on the valuation date. These market based awards are expensed on a straight-line basis over the requisite service period (75% vests at the end of the three-year performance period and 25% vests the following year). The following table presents the total shareholder return component of the long-term compensation awards for the four years ended December 31, 2025:
| 2025 Award |  | 2024 Award |  | 2023 Award |  | 2022 Award
Grant date | 2/27/2025 |  | 2/26/2024 |  | 3/2/2023 |  | 3/3/2022
Performance period | 1/1/25 - 12/31/27 |  | 1/1/24 - 12/31/26 |  | 1/1/23 - 12/31/25 |  | 1/1/22 - 12/31/24
Range of earnable shares — Low end of range | — |  |  | — |  |  | — |  |  | — |
Range of earnable shares — High end of range | 52,501 |  |  | 39,364 |  |  | 44,725 |  |  | 27,212 |
Shares determined | N/A (1) |  | N/A (1) |  | N/A (1) |  | 13,606 |
(1)The market conditions for this award have not yet been satisfied and the number of shares have not yet been determined. The long term awards subject only to continuing employment are expensed on a straight-line basis over the requisite service period (25% vests in each of the following four years). The following table presents the service only component of the long-term compensation awards for the four years ended December 31, 2025:
| 2025 Award |  | 2024 Award |  | 2023 Award |  | 2022 Award
Grant date | 2/27/2025 |  | 2/26/2024 |  | 3/2/2023 |  | 3/3/2022
Shares granted | 11,250 |  |  | 8,436 |  |  | 9,583 |  |  | 5,830 |
Grant date share price | $ | 179.99 |  |  | 179.17 |  |  | 165.83 |  |  | 193.54 |
Annual equity compensation awards The annual equity compensation awards include components based on certain annual Company performance measures and individual annual performance goals over the upcoming year. The Company performance measures for 2025 are: (i) funds from operations “FFO” per share, (ii) cash same property net operating income change, (iii) debt-to-EBITDAre ratio, and (iv) fixed charge coverage. The Company begins recognizing expense for its estimate of the shares that could be earned pursuant to these awards on the grant date; the expense is adjusted to estimated performance levels during the performance period and to actual upon the determination of the awards. The shares are expensed using the graded vesting attribution method which recognizes each separate vesting portion of the award as a separate award on a straight-line basis over the requisite service period (34% vests at the end of the one year performance period and 33% vests in each of the following two years). The following table presents the Company performance measures component of the annual equity compensation awards for the three years ended December 31, 2025:
| 2025 Award |  | 2024 Award |  | 2023 Award |  |  |  |
Grant date | 2/27/2025 |  | 2/26/2024 |  | 3/2/2023 |  |  |  |
Performance period | 1/1/25 - 12/31/25 |  | 1/1/24 - 12/31/24 |  | 1/1/23 - 12/31/23 |  |  |  |
Range of earnable shares — Low end of range | — |  |  | — |  |  | — |  |  |  |  |
Range of earnable shares — High end of range | 14,784 |  |  | 18,548 |  |  | 21,438 |  |  |  |  |
Shares determined | N/A (1) |  | 16,444 |  |  | 21,438 |  |  |  |  |
Grant date share price | $ | 179.99 |  |  | 179.17 |  |  | 165.83 |  |  |  |  |
(1)The performance conditions for this award have not yet been satisfied and the number of shares have not yet been determined. Any shares issued pursuant to the individual annual performance goals are determined by the Committee in its discretion following the performance period. The Company begins recognizing the expense for the shares on the grant date and expenses on a straight-line basis over the remaining service period (34% vests at the end of the one year performance period and 33% vests in each of the following two years). The following table presents the individual performance goals component of the annual equity compensation awards for the three years ended December 31, 2025:
| 2025 Award |  | 2024 Award |  | 2023 Award
Grant date | N/A (1) |  | 2/12/2025 |  | 2/14/2024
Performance period | 1/1/25 - 12/31/25 |  | 1/1/24 - 12/31/24 |  | 1/1/23 - 12/31/23
Range of earnable shares — Low end of range | — |  |  | — |  |  | — |
Range of earnable shares — High end of range | 4,501 |  |  | 5,652 |  |  | 5,358 |
Shares determined | N/A (1) |  | 4,670 |  |  | 4,814 |
Grant date share price | N/A (1) |  | $ | 178.86 |  |  | 183.46 |
(1)For this award, the performance conditions and grant date criteria under ASC 718, Compensation - Stock Compensation, have not yet been satisfied and the date of grant and resulting number of shares have not yet been determined. Equity compensation is also awarded to the Company’s non-executive officers, which are subject to service only conditions and expensed on a straight-line basis over the requisite service period (20% vests in each of the following five years). The total compensation expense is based upon the fair market value of the shares on the grant date. The following table presents the compensation awards to non-executive officers for the three years ended December 31, 2025:
| 2025 Award |  | 2024 Award |  | 2023 Award
Grant date | 8/25/2025 |  | 8/5/2024 |  | 6/20/2023
Shares granted | 14,250 |  |  | 12,150 |  |  | 11,325 |
Grant date share price | $ | 168.36 |  |  | 179.35 |  |  | 172.70 |
The Committee has adopted an Equity Award Retirement Policy (the “retirement policy”) which allows for accelerated vesting of unvested shares for retirement-eligible employees (defined as employees who meet certain age and years of service requirements). In order to qualify for accelerated vesting upon retirement, the eligible employees must provide required notification under the retirement policy and must retire from the Company. The Company has adjusted its stock-based compensation expense to accelerate the recognition of expense for retirement-eligible employees. Stock-based compensation cost for employees was $12,864,000, $11,729,000 and $11,013,000 for 2025, 2024 and 2023, respectively, of which $1,890,000, $2,017,000 and $2,812,000 were capitalized as part of the Company’s development costs for the respective years. As of December 31, 2025, there was $4,888,000 of unrecognized compensation cost related to unvested restricted stock compensation for employees and directors that is expected to be recognized over a weighted average period of 1.5 years. During the restricted period for granted and unvested awards, dividends are accrued based upon the number of shares expected to be awarded; accrued dividends are paid upon vesting of the awards. As of December 31, 2025, 2024 and 2023, accrued dividends on unvested restricted stock were $2,173,000, $1,617,000 and $1,921,000, respectively. Of the shares that vested in 2025, 2024 and 2023, 24,745 shares, 33,381 shares and 31,254 shares, respectively, were withheld by the Company to satisfy the tax obligations for those employees who elected this option as permitted under the applicable equity plan. Following is a summary of the total restricted shares granted, forfeited and delivered (vested) to employees with the related weighted average grant date fair value share prices for 2025, 2024 and 2023. As of the grant dates, the aggregate fair value of shares that were granted during 2025, 2024 and 2023 was $11,117,000, $11,270,000 and $8,562,000, respectively. As of the vesting dates, the aggregate fair value of shares that vested during 2025, 2024 and 2023 was $9,977,000, $14,324,000 and $11,304,000, respectively.
RESTRICTED STOCK ACTIVITY |  | Years Ended December 31,
| 2025 |  | 2024 |  | 2023
| Shares |  | Weighted Average Grant Date Fair Value |  | Shares |  | Weighted Average Grant Date Fair Value |  | Shares |  | Weighted Average Grant Date Fair Value
Unvested at beginning of year |  | 84,069 |  |  | $ | 160.72 |  |  | 80,282 |  |  | $ | 153.43 |  |  | 96,708 |  |  | $ | 131.79 |
Granted (1) (2) |  | 60,220 |  |  | 184.61 |  |  | 84,308 |  |  | 133.68 |  |  | 57,741 |  |  | 148.28 |
Forfeited |  | — |  |  | — |  |  | (2,545) |  |  | 156.45 |  |  | (1,015) |  |  | 144.79 |
Vested |  | (59,819) |  |  | 163.92 |  |  | (77,976) |  |  | 124.12 |  |  | (73,152) |  |  | 120.87 |
Unvested at end of year |  | 84,470 |  |  | 175.49 |  |  | 84,069 |  |  | 160.72 |  |  | 80,282 |  |  | 153.43 |
(1)Includes restricted shares granted during the year without performance or market conditions. Also includes restricted shares granted in previous years, for long-term and annual equity compensation awards for the Company's executive officers, for which performance based or market based conditions have been satisfied and the resulting number of shares have been determined during the year. (2)Does not include restricted shares subject to open performance periods. For the long-term equity compensation awards established in 2023 and 2024 and the long-term and annual equity compensation awards established in 2025, the number of shares depend on satisfaction of performance based or market based conditions, and the number of shares to be earned could range from zero to 155,875. Following is a vesting schedule of the total unvested shares for employees as of December 31, 2025:
Unvested Shares Vesting Schedule |  | Number of Shares
2026 |  | 38,566 |
2027 |  | 23,089 |
2028 |  | 11,984 |
2029 |  | 7,981 |
2030 |  | 2,850 |
Total Unvested Shares |  | 84,470 |
Directors Equity Awards The Board of Directors has adopted a policy under the 2023 Equity Plan pursuant to which awards will be made to non-employee Directors. The current policy provides that the Company shall automatically award an annual restricted share award to each non-employee Director who has been elected or re-elected as a member of the Board of Directors at the Annual Meeting. The number of shares shall be equal to $135,000 divided by the fair market value of a share on the date of such election. If a non-employee Director is elected or appointed to the Board of Directors other than at an Annual Meeting of the Company, the annual restricted share award shall be pro-rated. The restricted shares vest in full on the earlier of the one-year anniversary of the date of grant or the next annual meeting of shareholders following the date of grant, subject to the non-employee director’s continued service on the Board through such vesting date, subject to certain exceptions. The shares are expensed on a straight-line basis over the service period. The policy also provides that each new non-employee Director appointed or elected will receive an automatic award of restricted shares of Common Stock on the effective date of election or appointment equal to $25,000 divided by the fair market value of the Company’s Common Stock on such date. These restricted shares will vest 25% per year over a four-year period upon the performance of future service as a Director, subject to certain exceptions. The shares are expensed on a straight-line basis over the service period. Directors were granted 4,884, 5,040 and 4,134 shares of common stock as annual restricted share awards during 2025, 2024 and 2023, respectively. Stock-based compensation expense for directors was $819,000, $764,000 and $764,000 for 2025, 2024 and 2023, respectively. Following is a summary of the total restricted shares granted, forfeited and delivered (vested) to directors with the related weighted average grant date fair value share prices for 2025, 2024 and 2023. As of the grant dates, the aggregate fair value of shares that were granted during 2025, 2024 and 2023 was $811,000, $811,000 and $661,000, respectively. As of the vesting dates, the fair value of shares that vested during 2025, 2024 and 2023 was $842,000, $680,000 and $904,000, respectively.
Restricted Stock Activity: | Years Ended December 31,
2025 |  | 2024 |  | 2023
Shares |  | Weighted Average Grant Date Fair Value |  | Shares |  | Weighted Average Grant Date Fair Value |  | Shares |  | Weighted Average Grant Date Fair Value
Unvested at beginning of year | 5,104 |  |  | $ | 161.33 |  |  | 4,282 |  |  | $ | 160.15 |  |  | 5,800 |  |  | $ | 158.31 |
Granted | 4,884 |  |  | 165.99 |  |  | 5,040 |  |  | 160.87 |  |  | 4,134 |  |  | 159.79 |
Forfeited | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Vested | (5,072) |  |  | 161.10 |  |  | (4,218) |  |  | 159.58 |  |  | (5,652) |  |  | 158.00 |
Unvested at end of year | 4,916 |  |  | 166.20 |  |  | 5,104 |  |  | 161.33 |  |  | 4,282 |  |  | 160.15 |

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration